Argenx Se ARGX
NASDAQ ARGX
$1,033.15 -20.31 (-1.93%)
At close: Sep 4, 2026 · 4:00 PM EDT

Argenx Se (ARGX) Payables (2015 - 2026)

Argenx Se's (ARGX) quarterly Payables came in at $1.5 billion in Q2 2026, down 99.85% on a YoY basis from $1016.2 billion in Q2 2025, and up 19.57% quarter-over-quarter from $1.3 billion in Q4 2025.

Analysis

Argenx Se (ARGX) Payables (2015 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Payables for 12 consecutive years, with $1.5 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Payables fell 99.85% year-over-year to $1.5 billion; the trailing twelve-month figure through Jun 2026 stood at $1.5 billion (down 99.85% YoY), and the FY2025 full-year result was $1.3 billion, down 99.81% from the prior year.
  • Payables grew to $1.5 billion in Q2 2026 per ARGX's latest filing, from $1.3 billion in the prior quarter.
  • Across five years, Payables topped out at $1016.2 billion in Q2 2025 and bottomed at $257.7 million in Q2 2022.
  • Historically, Payables has averaged $218.5 billion across 5 years, with a median of $1.3 billion in 2025.
  • The sharpest annual moves came in 2023 and 2025: Payables slumped 99.86% in 2023, then surged 211675.45% in 2025.
  • Over 5 years, Payables stood at $295.7 billion in 2022, then plunged by 99.86% to $414.0 million in 2023, then soared by 156898.21% to $650.0 billion in 2024, then sank by 99.81% to $1.3 billion in 2025, then climbed by 19.57% to $1.5 billion in 2026.
  • According to Business Quant data, Payables over the past three periods registered $1.5 billion, $1.3 billion, and $1016.2 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 2.87 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 674.00 Mn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 429.50 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 1.16 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 1.52 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 167.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 108.02 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 403.90 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 428.93 Mn
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn 751.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.52 Bn
Dec 31, 2025 1.27 Bn
Jun 30, 2025 1,016.16 Bn
Dec 31, 2024 649.99 Bn
Jun 30, 2024 479.83 Mn
Dec 31, 2023 414.01 Mn
Jun 30, 2023 309.99 Mn
Dec 31, 2022 295.68 Bn
Jun 30, 2022 257.69 Mn
Dec 31, 2021 293.42 Bn
Jun 30, 2021 239.44 Mn
Dec 31, 2020 267.39 Bn
Jun 30, 2020 140.82 Mn
Dec 31, 2019 94.42 Mn
Jun 30, 2019 61.88 Mn
Dec 31, 2018 42.31 Mn
Jun 30, 2018 25.73 Mn
Dec 31, 2017 18.00 Mn
Jun 30, 2017 14.37 Mn
Dec 31, 2016 13.16 Mn